Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Moodys
Express Scripts
Farmers Insurance
Chinese Patent Office
Fish and Richardson
Healthtrust
Novartis
Deloitte

Generated: December 10, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021642

« Back to Dashboard

NDA 021642 describes NASCOBAL, which is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from one supplier. There are six patents protecting this drug and one Paragraph IV challenge. Additional details are available on the NASCOBAL profile page.

The generic ingredient in NASCOBAL is cyanocobalamin. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.

Summary for 021642

Tradename:1
Applicant:1
Ingredient:1
Patents:6
Formulation / Manufacturing:see details

Pharmacology for NDA: 021642

Ingredient-typeVitamin B 12

Suppliers and Packaging for NDA: 021642

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642 NDA Par Pharmaceutical , Inc 49884-270 49884-270-82 4 SPRAY in 1 CARTON (49884-270-82)
NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642 NDA Par Pharmaceutical , Inc 49884-270 49884-270-86 4 SPRAY in 1 BOTTLE (49884-270-86)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY, METERED;NASALStrength0.5MG/SPRAY
Approval Date:Jan 31, 2005TE:RLD:Yes
Patent:► SubscribePatent Expiration:Aug 1, 2024Product Flag?YSubstance Flag?Delist Request?
Patented Use:NASAL ADMINISTRATION OF CYANOCOBALAMIN
Patent:► SubscribePatent Expiration:Mar 12, 2024Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Aug 1, 2024Product Flag?YSubstance Flag?Delist Request?
Patented Use:CYANOCOBALAMIN ADMINISTRATION THROUGH NASAL INFUSION


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Moodys
McKinsey
Baxter
Covington
Federal Trade Commission
Mallinckrodt
Chubb
Dow
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot